Liver Cancer is the 7th most common cancer worldwide and ranks 4th most common in Singapore. Our lifestyles of having Char Kway Teow, Chicken rice and excessive consumption of soft drinks have not made it easy for our livers.
Fatty Liver is a condition where fat is being accumulated in liver cells. The consumption of drugs and alcohol are common causes of this disease. It can lead to inflammation and later scarring if left undetected. Therefore, early detection is essential to ensure that Liver Cancer Patients do not receive treatment too late. The danger is that, by the time Liver Cancer is detected, it will usually have spread to beyond the liver. Early cancers can only be treated by surgical removal (resection), destruction of the individual tumours, or liver transplantation.
To date, Singaporean research scientists and clinicians at the NCCS have been able to make a significant breakthrough in testing the effectiveness of drugs usable for certain patients. The NCCS team is now able to predict the outcomes of certain drugs when used by patients. The NCCS team does this by taking an extract of the tumour and testing it on a mouse till they get the desired result to give to patient. NCCS has found that two drugs from two giant pharmaceutical companies are more effective then the use of just one of these drugs. This has in turn led to the Phase I clinical trial testing this 2-drug combination in liver cancer patients as well as a shrinkage in tumour for some patients.
Through NCCS’ success, drug companies are using their testing Model as a platform to improve their own drug combinations.
NCCS will hold its 2nd campaign for Liver Cancer Awareness this year. The campaign will focus on how to avoid fatty liver, the risk of hepatitis and talk about the latest liver cancer treatments available.
In a bid to reach further into the heartlands, this year's public forums will be held at the Paya Lebar Kovan Community Centre in Hougang Street 21 on 12 and 13 September 2009. The forums will be held in both English and Mandarin. Attendees will receive free goodie bags as well as vouchers for free Hepatitis screening at the SingHealth Polyclinics.
Attendees will be able to gain more information about Liver Cancer through this campaign. Admission is free.
Time Programme
(English)
9:30-10 AM Registration
10 – 10:10PM Opening address by Guest of Honour Madam Cynthia Phua, MP for Aljunied GRC
10:10- 10:40 AM I have a fatty liver --What should I do? Can this lead to cancer? by Dr Tan Hui Hui
10:40-11:10 AM Hepatitis – The risks for me and my family by Dr Donald Poon
11:10 – 11:40 AM Liver Cancer -- The silent Killer by Dr Alexander Chung
11:40AM Refreshments & Voucher/goodie bag collection -
(Mandarin)
1:30-2 PM Registration -
2- 2:30PM I have fatty liver – What should I do? Can this lead to cancer? by A/Prof Chow Wan Cheng
2:30 -3PM Hepatitis—The risks for me & my family by A/Prof Koo Wen Hsin
3- 3:30PM Liver Cancer – The Silent Killer by Dr Cheow Peng Chung
3:30PM Refreshments & Voucher/goodie bag collection -
Public Form on 13th Sep Sunday
Time Programme
13 Sep, Sun 9:30-10AM Registration
(Mandarin) 10-10:30AM I have fatty liver – What should I do? Can this lead to cancer? A/Prof Chow WanCheng
10:30-11 AM Hepatitis—The risks for me & my family A/Prof Koo Wen Hsin
11-11:30AM Liver Cancer –The Silent Killer Dr Cheow Peng Chung
11:30AM Refreshments & Voucher/goodie bag collection
13 Sep, Sun
1:30 -2 PM Registration -
(English) 2- 2:30 PM I have fatty liver – What should I do? Can this lead to cancer? A/Prof Tan Chee Kiat
2:30-3PM Hepatitis – The risks for me & my family Dr Choo Su Pin
3-3:30PM Liver Cancer – The Silent Killer
3:30PM Refreshments & Voucher/goodie bag collection -
13 Sep, Sun
9:30 -10AM Registration
(Eng) 10 – 10:30AM I have fatty liver—What should I do? Can this lead to cancer? A/ Prof Tan Chee Kiat
2:30 -3PM Hepatitis – The risks for me & my family Dr Choo Su Pin
3- 3:30PM Liver Cancer – The Silent Killer Dr Wong Jen San
3:30PM Refreshments & Voucher/goodie bag collection
Fatty Liver is a condition where fat is being accumulated in liver cells. The consumption of drugs and alcohol are common causes of this disease. It can lead to inflammation and later scarring if left undetected. Therefore, early detection is essential to ensure that Liver Cancer Patients do not receive treatment too late. The danger is that, by the time Liver Cancer is detected, it will usually have spread to beyond the liver. Early cancers can only be treated by surgical removal (resection), destruction of the individual tumours, or liver transplantation.
To date, Singaporean research scientists and clinicians at the NCCS have been able to make a significant breakthrough in testing the effectiveness of drugs usable for certain patients. The NCCS team is now able to predict the outcomes of certain drugs when used by patients. The NCCS team does this by taking an extract of the tumour and testing it on a mouse till they get the desired result to give to patient. NCCS has found that two drugs from two giant pharmaceutical companies are more effective then the use of just one of these drugs. This has in turn led to the Phase I clinical trial testing this 2-drug combination in liver cancer patients as well as a shrinkage in tumour for some patients.
Through NCCS’ success, drug companies are using their testing Model as a platform to improve their own drug combinations.
NCCS will hold its 2nd campaign for Liver Cancer Awareness this year. The campaign will focus on how to avoid fatty liver, the risk of hepatitis and talk about the latest liver cancer treatments available.
In a bid to reach further into the heartlands, this year's public forums will be held at the Paya Lebar Kovan Community Centre in Hougang Street 21 on 12 and 13 September 2009. The forums will be held in both English and Mandarin. Attendees will receive free goodie bags as well as vouchers for free Hepatitis screening at the SingHealth Polyclinics.
Attendees will be able to gain more information about Liver Cancer through this campaign. Admission is free.
Time Programme
(English)
9:30-10 AM Registration
10 – 10:10PM Opening address by Guest of Honour Madam Cynthia Phua, MP for Aljunied GRC
10:10- 10:40 AM I have a fatty liver --What should I do? Can this lead to cancer? by Dr Tan Hui Hui
10:40-11:10 AM Hepatitis – The risks for me and my family by Dr Donald Poon
11:10 – 11:40 AM Liver Cancer -- The silent Killer by Dr Alexander Chung
11:40AM Refreshments & Voucher/goodie bag collection -
(Mandarin)
1:30-2 PM Registration -
2- 2:30PM I have fatty liver – What should I do? Can this lead to cancer? by A/Prof Chow Wan Cheng
2:30 -3PM Hepatitis—The risks for me & my family by A/Prof Koo Wen Hsin
3- 3:30PM Liver Cancer – The Silent Killer by Dr Cheow Peng Chung
3:30PM Refreshments & Voucher/goodie bag collection -
Public Form on 13th Sep Sunday
Time Programme
13 Sep, Sun 9:30-10AM Registration
(Mandarin) 10-10:30AM I have fatty liver – What should I do? Can this lead to cancer? A/Prof Chow WanCheng
10:30-11 AM Hepatitis—The risks for me & my family A/Prof Koo Wen Hsin
11-11:30AM Liver Cancer –The Silent Killer Dr Cheow Peng Chung
11:30AM Refreshments & Voucher/goodie bag collection
13 Sep, Sun
1:30 -2 PM Registration -
(English) 2- 2:30 PM I have fatty liver – What should I do? Can this lead to cancer? A/Prof Tan Chee Kiat
2:30-3PM Hepatitis – The risks for me & my family Dr Choo Su Pin
3-3:30PM Liver Cancer – The Silent Killer
3:30PM Refreshments & Voucher/goodie bag collection -
13 Sep, Sun
9:30 -10AM Registration
(Eng) 10 – 10:30AM I have fatty liver—What should I do? Can this lead to cancer? A/ Prof Tan Chee Kiat
2:30 -3PM Hepatitis – The risks for me & my family Dr Choo Su Pin
3- 3:30PM Liver Cancer – The Silent Killer Dr Wong Jen San
3:30PM Refreshments & Voucher/goodie bag collection
0 comments: